Phenobarbital Dosing in Pediatric Patients
For pediatric seizure management, phenobarbital should be administered as a loading dose of 15-20 mg/kg IV/IM followed by maintenance dosing of 3-5 mg/kg/day, with specific adjustments based on age, clinical context, and therapeutic drug monitoring. 1
Loading Dose Recommendations
Standard Loading Dose:
- 15-20 mg/kg IV or IM is the FDA-approved and guideline-supported loading dose for anticonvulsant use in children 1
- This achieves therapeutic blood levels of approximately 20 µg/mL shortly after administration 1
- For status epilepticus specifically, 15-20 mg/kg over 10-15 minutes IV is recommended 2
Critical Administration Points:
- IV administration rate should not exceed 60 mg/min in adults; proportionally slower in children 1
- When given IV, phenobarbital may require 15 minutes or more to reach peak brain concentrations 1
- Wait for anticonvulsant effect before administering additional doses to avoid excessive CNS depression 1
Maintenance Dose Recommendations
Standard Maintenance:
- 3-5 mg/kg/day divided into 1-2 doses 1
- For neonates with hypoxic-ischemic encephalopathy: 3 mg/kg/day appears optimal based on recent pharmacokinetic studies 3, 4
- Therapeutic serum levels: 10-25 µg/mL 1
Age-Specific Considerations:
- Higher per-kilogram doses are generally necessary in children compared to adults to achieve therapeutic levels 1
- Neonates and infants require careful monitoring as clearance increases with postnatal age 5
Special Clinical Situations
Severe Asphyxia/Hypoxic-Ischemic Encephalopathy:
- Use lower end of dosing range (15 mg/kg loading, 3 mg/kg/day maintenance) 6, 3
- Asphyxiated neonates have impaired hepatic drug metabolism and renal elimination, leading to elevated drug levels 4
- Loading doses >20 mg/kg frequently result in supratherapeutic levels in this population 4
Therapeutic Hypothermia:
- Significantly increases phenobarbital levels 4
- 100% of neonates receiving >20 mg/kg loading dose during therapeutic hypothermia had supratherapeutic levels 4
- Recommend 15-20 mg/kg loading dose maximum in this context with close therapeutic drug monitoring
ECMO Support:
- Requires higher doses: 30 mg/kg loading dose followed by 6-7 mg/kg/day maintenance 7, 5
- Phenobarbital clearance is 6-fold higher in children on concurrent CVVHDF compared to ECMO alone 7
- Volume of distribution increases significantly on ECMO, particularly with low albumin (<3 mg/dL) 5
Cardiac Surgery Patients:
- Loading doses of 20-30 mg/kg depending on albumin levels and ECMO status 5
- 30 mg/kg for albumin ≤3 mg/dL or patients on ECMO
- 20 mg/kg for albumin >3 mg/dL without ECMO
- Maintenance: 4-5 mg/kg/day 5
Route of Administration
Preferred Routes:
- IV or IM administration for acute seizure management 1
- IM injections must be deep into large muscle; maximum 5 mL per site 1
- Subcutaneous administration is contraindicated due to tissue irritation risk 1
IV Administration Safety:
- Use large veins; avoid dorsum of hand/wrist 1
- Never use varicose veins 1
- Intraarterial injection can cause gangrene and must be avoided 1
Monitoring and Dose Adjustment
Therapeutic Drug Monitoring:
- Essential in all pediatric patients, particularly those with:
Dose Reduction Indicated:
Common Pitfalls to Avoid
- Avoid continuous dosing until seizures stop - this leads to excessive brain concentrations and prolonged post-ictal depression 1
- Do not exceed recommended IV infusion rates - rapid administration increases risk of respiratory depression and hypotension 1
- Do not use loading doses >20 mg/kg in neonates with HIE undergoing therapeutic hypothermia without therapeutic drug monitoring 4
- Do not underdose patients on ECMO - they require substantially higher doses than standard recommendations 7, 5